Clinical Trial for Hidradenitis Suppurativa (22 Weeks)

For condition: Hidradenitis Suppurativa

Clinical Trial for Hidradenitis Suppurativa (22 Weeks)

Study Summary

Who Can Participate?
Adults aged 18 to 70 with hidradenitis suppurativa (HS) may be eligible to participate.

Inclusion Criteria

  • History of HS for 6 months or longer
  • Have at least 5 lesions (abscesses and/or inflammatory nodules) affecting at least 2 different body areas
  • Inadequate response to at least one course of antibiotics for the treatment of HS

Participant Information

  • Participate and receive study treatment at no cost
  • Regular visits with study doctors who specialize in treating HS
  • Will receive either an investigative intravenous (IV) infusion treatment (study drug) or a placebo
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • Participation will last about 22 weeks and involve about 9 visits to the study research site.
Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial